U.S. market regained some ground Tuesday after disappointing manufacturing data sent stocks sliding in the previous session. The Dow Jones Industrial Average gained 0.47 percent, while the S&P 500 Index rallied 0.76 percent. The Indexes have fallen approximately 6.8 percent and 5.0 percent, respectively, so far in 2014. The U.S. budget deficit is expected to fall to $514 billion in 2014, the lowest level seen in Obama’s tenure, according to a congressional report released Tuesday. “The biggest concern for investors right now is, is this the beginning of a bigger pullback in the market?” said Joseph Tanious, global market strategist at JPMorgan Asset Management, according to Bloomberg. “If you look at economic growth, the earnings season and the health of corporate America, all those things appear to be doing quite well.”
Entegris Inc. (NASDAQ: ENTG) shares traded in the range of $11.15 to $11.88 Tuesday before settling to close at $11.43, an increase of 11.19 percent. The stock appears to be facing some resistance at the $11.59 and $11.82 levels with some support at $11.26. The company announced that its Board of Directors has approved the acquisition of ATMI. Shares of Entegris have gained approximately 15.0 percent in the past year.
More information on Entegris and access to the free equity report can be found at:
HCA Holdings Inc. (NYSE: HCA) shares traded in the range of $46.02 to $50.57 Tuesday before settling to close at $48.52, an increase of 0.12 percent. The stock appears to be facing some resistance at the $49.02 and $51.72 levels with some support at $47.74. The company reported revenues were $8.836 billion for the fourth quarter of 2013, an increase of 4.8 percent year-over-year. Shares of HCA Holdings have gained approximately 25.0 percent in the past year.
More information on HCA Holdings and access to the free equity report can be found at:
Hologic, Inc. (NASDAQ: HOLX) shares traded in the range of $20.03 to $21.49 Tuesday before settling to close at $20.11, a decrease of 1.76 percent. The stock appears to be facing some resistance at the $20.53 and $21.71 levels with some support at $20.07. The company reported a net loss of $5.4 million for the first quarter of fiscal 2014, compared to a net income of $3.1 million a year ago. Shares of Hologic have fallen approximately 15.0 percent in the past year.
More information on Hologic and access to the free equity report can be found at:
Michael Kors Holdings Ltd. (NYSE: KORS) shares traded in the range of $89.22 to $93.18 Tuesday before settling to close at $89.91, an increase of 17.27 percent. The stock appears to have some support at the $89.22, $84.26 and $82.75 levels. The company reported total revenue for the third quarter of fiscal 2014 increased 59.0 percent year-over-year to $1.0 billion. Shares of Michael Kors have gained approximately 60.0 percent in the past year.
More information on Michael Kors and access to the free equity report can be found at:
Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.
Activate your always free membership by signing up at www.WallStreetFundamentals.com today.
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.
Wall Street Fundamentals